TIRUMALCHM
Thirumalai Chemicals Limited
Each stock's 10,000-path forecast, rendered as light.
Thirumalai Chemicals Limited (TIRUMALCHM) Stock Analysis & Case Study
Is TIRUMALCHM a good buy? The data-driven verdict.
Thirumalai Chemicals Limited (TIRUMALCHM) trades at ₹170,on the numbers it tread carefully, a Downstox Snapshot Score of 30/100.
On the numbers, Thirumalai Chemicals Limited (TIRUMALCHM) tread carefully, a Downstox Snapshot Score of 30/100, weighing expensive at 130.0× earnings, ROE of -11.8%, a 51% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
TIRUMALCHM fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How TIRUMALCHM ranks against the 2,373 companies in our screener
- TIRUMALCHM's market cap of 2,022 Cr ranks in the 50th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TIRUMALCHM's book value of ₹130 ranks in the 60th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TIRUMALCHM's promoter holding of 37.1% ranks in the 13th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TIRUMALCHM's 3-year profit (PAT) growth of -6.0% ranks in the 23rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TIRUMALCHM's 3-year revenue growth of -7.0% ranks in the 13th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TIRUMALCHM's debt-to-equity ratio of 1.39x is lower than 9% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is TIRUMALCHM overvalued? TIRUMALCHM P/E vs peers
TIRUMALCHM trades at 130.0× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
TIRUMALCHM share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of TIRUMALCHM history (16%/yr drift, 45%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| TIRUMALCHM 2027 | ₹95 | ₹169 | ₹300 | +1% |
| TIRUMALCHM 2028 | ₹76 | ₹170 | ₹380 | +1% |
| TIRUMALCHM 2029 | ₹63 | ₹171 | ₹463 | +2% |
| TIRUMALCHM 2030 | ₹55 | ₹172 | ₹538 | +3% |
| TIRUMALCHM 2031 | ₹48 | ₹174 | ₹621 | +3% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability TIRUMALCHM goes up, or doubles?
The bull case for TIRUMALCHM
- Low price-to-book of 1.31×, the market is paying little over the company's net assets.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹463.
The bear case & risks
- TIRUMALCHM's P/E of 130.0x is lower than 8% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- TIRUMALCHM's Piotroski F-Score is 0/8. A screener percentile is not available for it right now.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹63.
TIRUMALCHM volatility & expected range, how bumpy is the ride?
Over the last 9.8 years TIRUMALCHM compounded at 16%/year with annualized volatility of 45%. That volatility implies a 1-year 80% range of ₹95-₹300, the honest backbone behind any single price target.
TIRUMALCHM price forecast, the full 60-month probability fan
TIRUMALCHM price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds TIRUMALCHM hits common targets within the simulated horizon?
Full multi-horizon detail on the TIRUMALCHM price target & forecast page.
TIRUMALCHM Piotroski F-Score: 0/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. TIRUMALCHM scores 0/8, weak on the financial-strength checks.
TIRUMALCHM MTF margin & leverage across 10 brokers
Margin Trading Facility lets you buy TIRUMALCHM with part of the capital. Lower margin % = higher leverage. Rates compared across 10 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 36.36% | 2.8× |
| Zerodha | 36.32% | 2.8× |
| Groww | 36.41% | 2.7× |
| Dhan | 40.00% | 2.5× |
| Kotak Neo | 36.36% | 2.8× |
| Paytm Money | 63.41% | 1.6× |
| Pocketful | 36.37% | 2.7× |
| Anand Rathi | 36.32% | 2.8× |
| Bajaj Broking | 45.00% | 2.2× |
| Share IndiaCHEAPEST | 36.03% | 2.8× |
Compare every broker on the TIRUMALCHM MTF page.
About Thirumalai Chemicals Limited: sector, index & market-cap context
Thirumalai Chemicals Limited (TIRUMALCHM) is a small-cap NSE-listed company, with a market capitalisation of ₹2,050 Cr. See more stocks on our screener.
How the TIRUMALCHM Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Thirumalai Chemicals Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
TIRUMALCHM analysis, FAQs
Is Thirumalai Chemicals Limited (TIRUMALCHM) a good buy?
On the numbers, Thirumalai Chemicals Limited (TIRUMALCHM) tread carefully, a Downstox Snapshot Score of 30/100, weighing expensive at 130.0× earnings, ROE of -11.8%, a 51% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is TIRUMALCHM overvalued or undervalued?
TIRUMALCHM trades at 130.0× earnings, expensive versus the ~22× long-run Nifty average.
What is the TIRUMALCHM share price target for 2031?
TIRUMALCHM's probability-weighted 2031 median target is ₹174, with an 80% range of ₹48-₹621 (10,000-path Monte-Carlo).
What is the probability TIRUMALCHM doubles in 5 years?
The modelled probability of TIRUMALCHM reaching ₹336 (2×) within 5 years is 26%.
What is the bull case for TIRUMALCHM?
Low price-to-book of 1.31×, the market is paying little over the company's net assets.
What are the risks in TIRUMALCHM?
TIRUMALCHM's P/E of 130.0x is lower than 8% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. TIRUMALCHM's Piotroski F-Score is 0/8. A screener percentile is not available for it right now.